The speakers confirmed for the 2010 Summit include:

• Roch Doliveux, Chief Executive Officer, UCB (Belgium)
• Dag Andersson, Chief Executive Officer, Diaverum (Sweden)
• Prof. Dr. Günter Huhle, Eur. Medical Area Leader Diabetes, Janssen-Cilag (Germany)
• Prof. John R. Kimberly, Professor of Health Care Management, Wharton School (USA)
• Dr. Sri(dhar) Mosur, President and CEO, Jubilant Biosys (India)
• Harpal Singh, Non-Executive Director, Fortis Healthcare (India)
• Franz Walt, Head Diabetes Care EMEA & Lat Am, Roche Diagnostics (Switzerland)
• Dr. Matthias Weber, VP & GM, Global Diagnostic Cardiology, GE Healthcare (Germany)

Some of our speakers are profiled below:

Dr. Roch Doliveux

Doctor in Veterinarian Medicine from Maisons-Alfort (France), Roch Doliveux is also Laureate of the Faculty of Medicine, Créteil, and holds an MBA from INSEAD (France) with distinction.

He joined the pharmaceutical industry early, first at Ciba-Geigy (now Novartis) in Switzerland, in Peru and in France, and then at Schering-Plough Corporation in various positions, including President of Schering-Plough International. Then, Roch Doliveux joined the Pierre Fabre group as Chief Executive Officer of Pierre Fabre Pharmaceuticals.

Roch Doliveux joined UCB in October 2003 as Director General of the Pharma Sector and Deputy Chairman of the Executive Committee. He became CEO and Chairman of the Executive Committee of UCB Group on January 1, 2005. He is a member of the Board of Directors of UCB, as well as a member of the Board of the European Federation of Pharmaceutical Association (EFPIA), of the INSEAD International Council, the Science & Business Innovation Board, the Caring Entrepreneurship Fund (King Baudouin Foundation) and WELBIO (Walloon Institute for Life Lead Sciences).

Dr. Günter Huhle

Prof. Dr. med. Günter Huhle is Member of the Management Board Janssen-Cilag, Head of Medical and Scientific Affairs and Medical Affairs Leader for Diabetes and Metabolic disease in the Region Europe, Middle East and Africa. In this function he is responsible for Pharmacovigilance, Regulatory Affairs, Clinical trial execution, Medical information and Medical education including strategic planning, budget and resource allocation.

Günter Huhle received his MD and PhD from the University of Heidelberg and his Master of Science in Pharmaceutical Medicine from the University of Witten/Herdecke. He specialized in Internal Medicine and Haemostaseology and has been appointed University Lecturer for Internal Medicine at the University of Heidelberg.

Since 2001, Günter Huhle has held national and international senior Management positions in the pharmaceutical Industry until joining the Management board of Janssen Cilag in 2007. He is married and has two sons. 

Franz Thomas Walt

He is Swiss national with a business education (MBA) and he joined Roche in 1989. At Roche, he pursued an international career with postings in the USA, Asia Pacific, Iberia, Latin America and Europe, becoming a truly global manager with the necessary cultural sensitivity and flexibility.

Today,he is looking back on twenty-two years of experience in the health care industry, including pharmaceuticals, diagnostics and medical devices. During these years, he worked not only in different parts of the world for different parts of our business but also in various functions.

He has  the whole range of experiences, starting out as a sales representative and working his way up to General Manager and Regional Manager (Responsible for a Group of Country Organizations). For eleven years, he has been GM/Region Head and a member of the corresponding global committees (DiaEC/Diagnostics Executive Committee, DCEC/Diabetes Executive Committee). This gave him the opportunity to gain first hand insights into both how to develop a strategy and how to implement it.  He also participated in the decisions along the entire value chain from R&D to commercialization as a member of these committees.

He has a proven performance track record ranging from entering new markets (e.g. China and India), achieving top and bottom line goals in emerging and mature markets to crisis/turnaround management (e.g. turnaround Diabetes Care EMEA). He is passionate about what he is doing and it inspires him to lead, coach and motivate international and interdisciplinary teams towards achieving challenging goals.

Dag Andersson

Dag Andersson is the President and CEO of Diaverum, one of the world’s largest private providers of renal services. The company operates more than 210 dialysis centres in Europe, Latin America and Australia.Diaverum was acquired by Bridgepoint in 2007 when the clinic business (at that time called Gambro Health Care) was divested from the Gambro Group.

Mr Andersson has a long experience of successfully managing private equity owned healthcare businesses. Before joining Diaverum in January 2008, he was the president of Mölnlycke Health Care’s Surgical Division, and prior to that he headed the company’s UK operations.

Prior to Mölnlycke Health Care, Mr Andersson worked at SKF in various positions.He holds an MBA from INSEAD and a Bachelor of Economics from Stockholm School of Economics. Mr Andersson lives in Munich, where the corporate office of Diaverum is located.

Prof. John R. Kimberly 

Dr. Kimberly is the Henry Bower Professor of Entrepreneurial Studies and Professor of Management, Health Care Systems, and Sociology at the Wharton School of the University of Pennsylvania. He recently spent two years at INSEAD as a visiting professor, teaching and conducting research.  He also contributes to the INSEAD Healthcare Management Initiative and manages the INSEAD-Wharton Alliance as executive director, reporting to the deans of Wharton and INSEAD.

His research areas include: Organizational Design, Organizational Change, Institutional Creation, Health Policy and Managerial Innovation.

 Harpal Singh

Mr. Harpal Singh, graduated with a B.A. (Honors) degree in Economics from St. Stephen’s College, Delhi and holds a B.S. degree in Economics and a Master’s degree in Public Affairs from the California State University at Hayward (C.S.C.H.), California, U.S.A. Mr. Harpal Singh has had diverse and wide-ranging experience of over 35 years in the corporate sector and has held senior positions in various TATA group companies, Hindustan Motors Limited, Mahindra and Mahindra Limited and Shaw Wallace.

Very active in public life, Mr. Harpal Singh serves and has been on the Board of some of the leading schools in India. He is a Member of the Board and of the Executive Committee of Public Health Foundation of India. He is a Member of the Board of Advisors of the National Institute of Information Technologies (NIIT) University and a member of its Board of Management. He is also a Member of the Punjab Chief Minister’s Advisory Committee on Industrial Growth and Development of Relevant Infrastructure. He was National Chairman of the Confederation of Indian Industry (CII) Committee on Public Health and a Member of the CII National Committee on Healthcare and the National Committee on Primary and Secondary Education and past Chairman of CII Punjab State Council. He is founder Chairman Trustee of the Chronic Care Foundation and is a Board Member of the Durlabji Trust, which runs a large charitable hospital in Jaipur.

More speaker biographies to follow...

Back to top